As of 2025-07-20, the Intrinsic Value of Aoxing Pharmaceutical Company Inc (AOXG) is 0.23 USD. This AOXG valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.01 USD, the upside of Aoxing Pharmaceutical Company Inc is 3,409.30%.
The range of the Intrinsic Value is 0.11 - 0.51 USD
Based on its market price of 0.01 USD and our intrinsic valuation, Aoxing Pharmaceutical Company Inc (AOXG) is undervalued by 3,409.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 0.11 - 0.51 | 0.23 | 3409.3% |
| DCF (Growth 10y) | 0.18 - 0.69 | 0.34 | 4978.4% |
| DCF (EBITDA 5y) | 0.45 - 0.83 | 0.63 | 9474.0% |
| DCF (EBITDA 10y) | 0.37 - 0.96 | 0.61 | 9197.4% |
| Fair Value | -0.13 - -0.13 | -0.13 | -2,064.47% |
| P/E | (0.18) - 1.40 | 0.47 | 7049.6% |
| EV/EBITDA | (0.01) - 0.61 | 0.19 | 2718.5% |
| EPV | (0.08) - 0.09 | 0.00 | -52.0% |
| DDM - Stable | (0.02) - (0.37) | (0.20) | -3089.9% |
| DDM - Multi | 0.03 - 0.50 | 0.06 | 759.0% |
| Market Cap (mil) | 0.53 |
| Beta | -0.70 |
| Outstanding shares (mil) | 80.83 |
| Enterprise Value (mil) | 21.18 |
| Market risk premium | 4.60% |
| Cost of Equity | 28.35% |
| Cost of Debt | 18.18% |
| WACC | 13.63% |